Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 3 Cancer Trials

Virginia

Phase 3 cancer trials in Virginia

139 Phase 3 cancer studies are recruiting participants at sites in 40 cities across Virginia as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 306-7888
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Virginia by city

Cities with the most studies recruiting right now.

Every Virginia city with a recruiting study

By research area: Lung Cancer (45), Breast Cancer (36), Lymphoma (25), Prostate Cancer (19), Pancreatic Cancer (8), Melanoma (6).

Richmond (69), Fairfax (54), Charlottesville (40), Midlothian (30), Norfolk (26), Roanoke (23), Mechanicsville (16), South Hill (13), Fredericksburg (11), Winchester (11), Lynchburg (9), Blacksburg (8), Falls Church (6), Fishersville (6), McLean (6), Woodbridge (6), Wytheville (6), Leesburg (5), Tappahannock (5), Salem (4), Alexandria (3), Bristol (3), Chesapeake (3), Fort Belvoir (3), Hampton (3), Low Moor (3), Virginia Beach (3), Williamsburg (3), Arlington (2), Burke (2), Newport News (2), Norton (2), Portsmouth (2), Christiansburg (1), Culpeper (1), Gainesville (1), Manassas (1), Quinton (1), Reston (1), Roanake (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Virginia

Basic details from each study's public record (the 12 most recently updated of 139). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Fredericksburg · Midlothian · Norfolk · and 1 more U.S. location
    Registry record
    NCT06393374 · updated
  2. Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Fishersville · Lynchburg · Mechanicsville · and 2 more U.S. locations
    Registry record
    NCT07391774 · updated
  3. A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Norfolk
    Registry record
    NCT06841354 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Virginia on ClinicalTrials.gov.

Lung cancer: recently updated in Virginia

  1. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Fredericksburg · Lynchburg · Richmond · and 1 more U.S. location
    Registry record
    NCT06498635 · updated
  2. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Recruiting in
    Blacksburg · Charlottesville · Fairfax · and 1 more U.S. location
    Registry record
    NCT06767514 · updated
  3. Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Fairfax
    Registry record
    NCT07195695 · updated
  4. Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy and With Tarlatamab, Alone or With Chemotherapy, in Adult Participants With Extensive-Stage Small Cell Lung Cancer

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Blacksburg · Chesapeake · Hampton · and 8 more U.S. locations
    Registry record
    NCT07226999 · updated
  5. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Fairfax · Norfolk · Richmond
    Registry record
    NCT06623422 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Virginia on ClinicalTrials.gov.

Lymphoma: recently updated in Virginia

  1. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Charlottesville · Richmond
    Registry record
    NCT06337318 · updated
  2. SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Nuvation Bio Inc.
    Recruiting in
    Charlottesville · Fairfax
    Registry record
    NCT05303519 · updated
  3. A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Charlottesville
    Registry record
    NCT05947851 · updated
  4. A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Charlottesville · Fairfax · Richmond
    Registry record
    NCT06136559 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Virginia on ClinicalTrials.gov.

Ask about studies in Virginia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 3, including combined Phase 2/3, as each study is coded in the registry.

Phase 3 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 306-7888

or send a short form

How should we reach you?

Call